Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repurposing Low-Dose Clonidine for PTSD in Veterans
NCT04877093Phase 3Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in post-traumatic stress disorder (PTSD), sponsored by Wake Forest University Health Sciences. Started Jun 2023; status: recruiting.
02
Drugs
clonidine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04877093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04877093.